Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Oluseye O Bolaji"'
Autor:
Olufunmilola O Abolurin, Adebanjo J Adegbola, Oyeku A Oyelami, Samuel A Adegoke, Oluseye O Bolaji
Publikováno v:
Nigerian Postgraduate Medical Journal, Vol 25, Iss 1, Pp 13-16 (2018)
Background and Aim: Vitamin A deficiency (VAD) constitutes a major nutritional concern in developing countries. It contributes significantly to the morbidity and mortality of under-five children and can result in impaired resistance to infection as w
Externí odkaz:
https://doaj.org/article/294d954fd83f4f5a88fe45ee32da0424
Autor:
Elisha A. Nelson, Ibrahim O. Ahmed, Rahman A. Bolarinwa, Babatunde A. Adeagbo, Adebanjo J. Adegbola, Lateef Salawu, Oluseye O. Bolaji, Muheez A. Durosinmi
Publikováno v:
BMC Research Notes, Vol 17, Iss 1, Pp 1-7 (2024)
Abstract Background In Nigeria, since 2002, Imatinib mesylate (glivec®) has been available freely to chronic myeloid leukaemia (CML) patients but only at a tertiary health care centre in the southwestern part of the country. Despite this, it is not
Externí odkaz:
https://doaj.org/article/230e939148a844e3a98b620494bda0b2
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 9, Iss 1, Pp 1-9 (2023)
Abstract Background As per current treatment guidelines, artemether-lumefantrine and efavirenz-based antiretroviral therapy are recommended drugs for falciparum malaria and human immunodeficiency virus (HIV) infections, respectively. A liquid chromat
Externí odkaz:
https://doaj.org/article/0419f1cb7d2641dca37de9ff19725fa7
Autor:
Adebanjo J. Adegbola, Omotade A. Ijarotimi, Akaninyene E. Ubom, Bukola A. Adesoji, Olajide E. Babalola, Emma F. Hocke, Helle Hansson, Andria Mousa, Oluseye O. Bolaji, Michael Alifrangis, Cally Roper
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-12 (2023)
Abstract Background Malaria is a major public health issue with substantial risks among vulnerable populations. Currently, the World Health Organization (WHO) recommends SP-IPTp in the second and third trimesters. However, the efficacy of SP-IPTp is
Externí odkaz:
https://doaj.org/article/57dcc0a36950423ca53c83c38ae04cef
Autor:
Adeola Fowotade, Folasade Bamidele, Boluwatife Egbetola, Adeniyi F. Fagbamigbe, Babatunde A. Adeagbo, Bolanle O. Adefuye, Ajibola Olagunoye, Temitope O. Ojo, Akindele O. Adebiyi, Omobolanle I. Olagunju, Olabode T. Ladipo, Abdulafeez Akinloye, Adedeji Onayade, Oluseye O. Bolaji, Steve Rannard, Christian Happi, Andrew Owen, Adeniyi Olagunju
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundThe nitazoxanide plus atazanavir/ritonavir for COVID-19 (NACOVID) trial investigated the efficacy and safety of repurposed nitazoxanide combined with atazanavir/ritonavir for COVID-19.MethodsThis is a pilot, randomized, open-label multicent
Externí odkaz:
https://doaj.org/article/6ec8b0e393c14d61b51ccf329a597ef4
Autor:
Ayorinde Adehin, PhD, Sharon I. Igbinoba, PhD, Julius O. Soyinka, PhD, Cyprian O. Onyeji, PhD, Chinedum P. Babalola, PhD, Oluseye O. Bolaji, PhD
Publikováno v:
Current Therapeutic Research, Vol 91, Iss , Pp 33-38 (2019)
ABSTRACT: Background: The varied disposition of the antimalarial quinine partly explains its poor tolerance and toxicity in humans. Objective: Using a population approach, the disposition of quinine in healthy subjects and patients with acute uncompl
Externí odkaz:
https://doaj.org/article/1625d798358d4f67b942c59570f78b94
Autor:
Abdulafeez Akinloye, Oluwasegun I. Eniayewu, Adeniyi Olagunju, Oluseye O. Bolaji, Babatunde Ayodeji Adeagbo
Publikováno v:
THERAPEUTIC DRUG MONITORING
BACKGROUND Dolutegravir is currently the preferred component of first-line antiretroviral therapy. To facilitate clinical pharmacology studies in key populations, quantitative analytical methods compatible with microsampling and adaptable to resource
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea9628b36ef162106eb55427416a8a7
https://doi.org/10.1097/ftd.0000000000000929
https://doi.org/10.1097/ftd.0000000000000929
Publikováno v:
Pharmacogenomics. 21:1289-1297
Aim: We aimed to assess the effect of a functional polymorphism of CYP3A5 on lumefantrine pharmacokinetics. Patients & methods: Sixty-nine women diagnosed with malaria received standard doses of artemether–lumefantrine. Concentration–time data fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0bd643195656727a1a047e14357508a
https://doi.org/10.2217/pgs-2020-0081
https://doi.org/10.2217/pgs-2020-0081
Autor:
Tony Phan, Akintunde Oluseto Akinlalu, Christopher B. Fox, Elize Willenburg, Babatunde Ayodeji Adeagbo, Jeff Guderian, Caryn Fenner, Oluseye O. Bolaji, Gerhardt Boukes
Publikováno v:
ACS Omega
ACS Omega, Vol 5, Iss 48, Pp 31306-31313 (2020)
ACS Omega, Vol 5, Iss 48, Pp 31306-31313 (2020)
Tuberculosis (TB) remains a foremost poverty-related disease with a high rate of mortality despite global immunization with Bacille Calmette-Guerin (BCG). Several adjuvanted recombinant proteins are in clinical development for TB to protect against t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::321a4be996774e3c53b87a3711f05368
http://europepmc.org/articles/PMC7726955
http://europepmc.org/articles/PMC7726955
Autor:
Martin A. Kennedy, Oluseye O. Bolaji, Olalekan Olasehinde, Ayorinde Adehin, Olusegun I. Alatise, Julius O. Soyinka
Publikováno v:
Breast Cancer: Targets and Therapy. 12:123-130
Estrogen-receptor positivity in tumour, often requiring long-term tamoxifen therapy, is thought to characterise between 43% and 65% of breast cancer cases in Nigeria. The patient population is further marked by late-stage diagnosis which significantl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36c723bc693bbfac7582b90e45c44639
https://doi.org/10.2147/bctt.s266314
https://doi.org/10.2147/bctt.s266314